advertisement
11.13.4 Betablocker and prostaglandin (15)
Showing records 1 to 15
Display all abstracts in classification 11.13.4 Betablocker and prostaglandin
Search within classification 11.13.4 Betablocker and prostaglandin72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Aihara M
Acta Ophthalmologica 2017; 95: e720-e726
73055 Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China
Sun X
Patient preference and adherence 2017; 11: 845-852
72780 Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination
Akyol N
Cutaneous and Ocular Toxicology 2017; 0: 1-7
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Adachi M
Acta Ophthalmologica 2017; 95: e720-e726
72780 Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination
Kalkisim A
Cutaneous and Ocular Toxicology 2017; 0: 1-7
73055 Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China
Lin M; Duan X
Patient preference and adherence 2017; 11: 845-852
72780 Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination
Turk A
Cutaneous and Ocular Toxicology 2017; 0: 1-7
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Matsuo H
Acta Ophthalmologica 2017; 95: e720-e726
72780 Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination
Kola M
Cutaneous and Ocular Toxicology 2017; 0: 1-7
73055 Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China
Zhang C
Patient preference and adherence 2017; 11: 845-852
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Togano T
Acta Ophthalmologica 2017; 95: e720-e726
73055 Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China
Ming J
Patient preference and adherence 2017; 11: 845-852
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Fukuchi T
Acta Ophthalmologica 2017; 95: e720-e726
72780 Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination
Imamoglu HI
Cutaneous and Ocular Toxicology 2017; 0: 1-7
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Sasaki N;
Acta Ophthalmologica 2017; 95: e720-e726
